Figure 1. Comparison efavirenz pharmacokinetics between DILI cases and controls: mean log transformed plasma efavirenz (ng/mL).
8-hydroxyefavirenz (ng/mL) and efavirenz/8-hydroxyefavirenz ratio (MR) was compared between patients who developed concomitant efavirenz-based HAART and rifampicin based anti-tubercular drugs induced liver injury (cases) and those who did not (controls).
